Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 9, 2005, Pages 1147-1151

  Corsonello, Andrea ^a,f   Pedone, Claudio ^b   Corica, Francesco ^c   Mazzei, Bruno ^a   Di Iorio, Angelo ^d   Carbonin, Pierugo ^b   Incalzi, Raffaele Antonelli ^b,e  

^a INRCA   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CEPHALOSPORIN DERIVATIVE; CREATININE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; GLIBENCLAMIDE; INSULIN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PENICILLIN DERIVATIVE; PSYCHOTROPIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BRADYCARDIA; CALCULATION; COGNITIVE DEFECT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG INDUCED DISEASE; EDEMA; ELDERLY CARE; FEMALE; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HAZARD ASSESSMENT; HEADACHE; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; HYPOTENSION; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SCREENING; SOMNOLENCE;

EID: 25644452780     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.9.1147     Document Type: Article

References (21)

1. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289:3273-3277.
2. Lindeman RD. Assessment of renal function in the old. Special considerations. Clin Lab Med. 1993;13:269-277.
3. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc. 1991;39:1093-1099.
4. Carosella L, Pahor M, Pedone C, Zuccala G, Manto A, Carbonin P. Pharmacosurveillance in hospitalized patients in Italy. Study design of the 'Gruppo Italiano di Farmacovigilanza nell'Anziano' (GIFA). Pharmacol Res. 1999;40:287-295.
5. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
6. Tierney LM, McPhee S, Papadakis MA. Current Medical Diagnosis and Treatment. 38th ed. Stanford, CT: Appleton & Lange; 1999.
7. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney Diseases Outcome Quality Initiative. Am J Kidney Dis. 2002;39:S1-S246.
8. Jitapunkul S, Pillay I, Ebrahim S. The abbreviated mental test: its use and validity. Age Ageing. 1991;20:332-336.
9. Rocca WA, Bonaiuto S, Lippi A, et al. Validation of the Hodkinson abbreviated mental test as a screening instrument for dementia in an Italian population. Neuroepidemiology. 1992;11:288-295.
10. Pahor M, Chrischilles, EA, Guralnik JM, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994;10:405-411.
11. World Health Organization (WHO). International Drug Monitoring: The Role of the Hospital. WHO Technical Report Series No. 425, 1969.
12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
13. Yesil S, Yesil M, Bayata S, Postaci N. ACE inhibitors and cough. Angiology. 1994;45:805-808.
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
15. Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes Metab. 2000;26 Suppl 4:73-85.
16. Emslie-Smith AM, Boyle DI, Evans JM, Sullivan F, Morris AD; DARTS/MEMO Collaboration. Contraindications to metformin therapy in patients with Type 2 diabetes-a population-based study of adherence to prescribing guidelines. Diabet Med. 2001;18:483-488.
17. Biesenbach G, Raml A, Schmekal B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in nephropathic Type I and insulin-treated Type 2 diabetic patients. Diabet Med. 2003;20:642-645.
18. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004;65:1031-1040.
19. Yokoyama H, Tomonaga O, Hirayama M, et al. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia. 1997;40:405-411.
20. Keane WF, Lyle PA; Reduction in Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan Study. Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study. Am J Kidney Dis. 2003;41(3 Suppl 1):S22-S25.
21. Ueda H, Ishimura E, Shoji T, et al. Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care. 2003;26:1530-1534.